Isotretinoína oral en dosis bajas en el tratamiento del acné moderado
Honeyman, Juan.
Dermatol. argent
; 4(4): 338-44, oct.-dic. 1998. tab
Artículo en Español | BINACIS | ID: bin-15308
Documentos relacionados
Assessing the Impact of Oral Isotretinoin on the Menstrual Cycle: A Prospective Study on Predictors of Menstrual Irregularities.
Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process.
How safe and effective is prescribing oral isotretinoin to treat acne in patients on renal dialysis? A systematic review.
Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne.
Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects.
Acne fulminans induced by a low dose isotretinoin: case report and review of the literature.
Challenges to Prescribing Isotretinoin to Patients at a Safety Net Hospital Dermatology Clinic.
Perceptions about oral isotretinoin treatment.
Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin.
Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series.